William Hoffman - 16 Apr 2024 Form 4 Insider Report for Inari Medical, Inc.

Role
Director
Signature
/s/ Shannon Trevino, attorney-in-fact for William Hoffman
Issuer symbol
N/A
Transactions as of
16 Apr 2024
Net transactions value
-$58,040
Form type
4
Filing time
18 Apr 2024, 18:38:03 UTC
Previous filing
03 Apr 2024
Next filing
26 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $58,040 -1,451 -0.14% $40.00 999,782 16 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.